The Minimal Important Difference of Exercise Tests in Severe COPD

Overview

Journal Eur Respir J

Specialty Pulmonary Medicine

Date 2010 Aug 10

PMID 20693247

Citations 137

Authors

M A Puhan

D Chandra

Z Mosenifar

A Ries

B Make

N N Hansel

R A Wise

F Sciurba

Affiliations

Soon will be listed here.

Abstract

Our aim was to determine the minimal important difference (MID) for 6-min walk distance (6MWD) and maximal cycle exercise capacity (MCEC) in patients with severe chronic obstructive pulmonary disease (COPD). 1,218 patients enrolled in the National Emphysema Treatment Trial completed exercise tests before and after 4-6 weeks of pre-trial rehabilitation, and 6 months after randomisation to surgery or medical care. The St George's Respiratory Questionnaire (domain and total scores) and University of California San Diego Shortness of Breath Questionnaire (total score) served as anchors for anchor-based MID estimates. In order to calculate distribution-based estimates, we used the standard error of measurement, Cohen's effect size and the empirical rule effect size. Anchor-based estimates for the 6MWD were 18.9 m (95% CI 18.1-20.1 m), 24.2 m (95% CI 23.4-25.4 m), 24.6 m (95% CI 23.4-25.7 m) and 26.4 m (95% CI 25.4-27.4 m), which were similar to distribution-based MID estimates of 25.7, 26.8 and 30.6 m. For MCEC, anchor-based estimates for the MID were 2.2 W (95% CI 2.0-2.4 W), 3.2 W (95% CI 3.0-3.4 W), 3.2 W (95% CI 3.0-3.4 W) and 3.3 W (95% CI 3.0-3.5 W), while distribution-based estimates were 5.3 and 5.5 W. We suggest a MID of 26 ± 2 m for 6MWD and 4 ± 1 W for MCEC for patients with severe COPD.

Citing Articles

Clinical improvements after endoscopic lung volume reduction with valves in patients with advanced emphysema and a 6-min walk test ≤140 m at baseline.

Saccomanno J, Kilic L, Sgarbossa T, Neumann K, Stanzel F, Holland A ERJ Open Res. 2025; 11(1.

PMID: 39811547 PMC: 11726540. DOI: 10.1183/23120541.00410-2024.

Outcome and safety 90 days after combined airway valve treatment of the right upper and middle lobes in patients with severe pulmonary emphysema.

Dittrich A, De Pace C, Brock J, Trudzinski F, Heussel C, Eberhardt R Respir Res. 2025; 26(1):4.

PMID: 39762833 PMC: 11706069. DOI: 10.1186/s12931-024-03069-6.

Widening the selection criteria for lung volume reduction surgery.

Vandervelde C, Everaerts S, Weder W, Dooms C, Slebos D, Janssens W Eur Respir J. 2024; 65(1.

PMID: 39715645 PMC: 11736308. DOI: 10.1183/13993003.00829-2024.

Clinically important changes and adverse events with centre-based or home-based pulmonary rehabilitation in chronic respiratory disease: A systematic review and meta-analysis.

Bondarenko J, Dal Corso S, Dillon M, Singh S, Miller B, Kein C Chron Respir Dis. 2024; 21:14799731241277808.

PMID: 39187265 PMC: 11348370. DOI: 10.1177/14799731241277808.

Comparison of a Supervised Home-Based Tele-Rehabilitation with Center-Based Pulmonary Rehabilitation: Protocol for a Randomized Non-Inferiority Multicenter Study in Ningxia.

Xin H, Wei S, Zheng H, Qi Y, Xu S, Wang B Int J Chron Obstruct Pulmon Dis. 2024; 19():1707-1719.

PMID: 39081777 PMC: 11287464. DOI: 10.2147/COPD.S467945.

References

Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A . A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003; 348(21):2059-73. DOI: 10.1056/NEJMoa030287. View

Wyrwich K, Tierney W, Wolinsky F . Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999; 52(9):861-73. DOI: 10.1016/s0895-4356(99)00071-2. View

Sutherland E, Make B . Maximum exercise as an outcome in COPD: minimal clinically important difference. COPD. 2006; 2(1):137-41. DOI: 10.1081/copd-200051358. View

Tojo N, Ichioka M, Chida M, Miyazato I, Yoshizawa Y, Miyasaka N . Pulmonary exercise testing predicts prognosis in patients with chronic obstructive pulmonary disease. Intern Med. 2005; 44(1):20-5. DOI: 10.2169/internalmedicine.44.20. View

Redelmeier D, Bayoumi A, Goldstein R, Guyatt G . Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med. 1997; 155(4):1278-82. DOI: 10.1164/ajrccm.155.4.9105067. View

Puhan M, Guyatt G, Goldstein R, Mador J, McKim D, Stahl E . Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Respir Med. 2006; 101(2):308-16. DOI: 10.1016/j.rmed.2006.04.023. View

Pinto-Plata V, Cote C, Cabral H, Taylor J, Celli B . The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004; 23(1):28-33. DOI: 10.1183/09031936.03.00034603. View

Verrill D, Barton C, Beasley W, Lippard W . The effects of short-term and long-term pulmonary rehabilitation on functional capacity, perceived dyspnea, and quality of life. Chest. 2005; 128(2):673-83. DOI: 10.1378/chest.128.2.673. View

Ries A . Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD. 2006; 2(1):105-10. DOI: 10.1081/copd-200050655. View

10.

Peytremann-Bridevaux I, Staeger P, Bridevaux P, Ghali W, Burnand B . Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am J Med. 2008; 121(5):433-443.e4. DOI: 10.1016/j.amjmed.2008.02.009. View

11.

Wise R, Brown C . Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD. 2006; 2(1):125-9. DOI: 10.1081/copd-200050527. View

12.

Puhan M, Mador M, Held U, Goldstein R, Guyatt G, Schunemann H . Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J. 2008; 32(3):637-43. DOI: 10.1183/09031936.00140507. View

13.

Puhan M, Garcia-Aymerich J, Frey M, Ter Riet G, Anto J, Agusti A . Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009; 374(9691):704-11. DOI: 10.1016/S0140-6736(09)61301-5. View

14.

Eakin E, Resnikoff P, Prewitt L, Ries A, Kaplan R . Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest. 1998; 113(3):619-24. DOI: 10.1378/chest.113.3.619. View

15.

Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt G . Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002; (3):CD003793. DOI: 10.1002/14651858.CD003793. View

16.

Jones P, Quirk F, Baveystock C . The St George's Respiratory Questionnaire. Respir Med. 1991; 85 Suppl B:25-31; discussion 33-7. DOI: 10.1016/s0954-6111(06)80166-6. View

17.

. Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg. 1999; 118(3):518-28. DOI: 10.1016/s0022-5223(99)70191-1. View

18.

Schunemann H, Guyatt G . Commentary--goodbye M(C)ID! Hello MID, where do you come from?. Health Serv Res. 2005; 40(2):593-7. PMC: 1361157. DOI: 10.1111/j.1475-6773.2005.00374.x. View

19.

Guyatt G, Osoba D, Wu A, Wyrwich K, Norman G . Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002; 77(4):371-83. DOI: 10.4065/77.4.371. View

20.

Puhan M, Frey M, Buchi S, Schunemann H . The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2008; 6:46. PMC: 2459149. DOI: 10.1186/1477-7525-6-46. View